Summary
This business operates a platform that analyzes RNA to detect diseases, monitor health, and develop next-generation RNA therapeutics. Their OneRNA® platform allows for the repurposing of approved drugs tailored to individual patients and aims to expedite the development of novel RNA therapies. The focus is on cancer treatment, particularly breast and ovarian cancers, utilizing comprehensive RNA analysis to inform treatment decisions and improve patient outcomes.
Based on content on genomicexpression.com
No similar companies found